tradingkey.logo
tradingkey.logo
검색

GeneDx Holdings Corp

WGS
관심 목록에 추가
71.710USD
+3.060+4.46%
종가 07/01, 16:00ET시세는 15분 지연됩니다
2.13B시가총액
손실P/E TTM

GeneDx Holdings Corp

71.710
+3.060+4.46%

자세한 내용은 GeneDx Holdings Corp 회사

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp 정보

종목 코드 WGS
회사 이름GeneDx Holdings Corp
상장일Sep 04, 2020
CEOStueland (Katherine A)
직원 수1000
유형Ordinary Share
회계 연도 종료Sep 04
주소333 Ludlow Street
도시STAMFORD
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호06902
전화18887291206
웹사이트https://sema4.com/
종목 코드 WGS
상장일Sep 04, 2020
CEOStueland (Katherine A)

GeneDx Holdings Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

자주 묻는 질문

GeneDx Holdings Corp의 상위 5대 주주는 누구인가요?

GeneDx Holdings Corp의 상위 5대 주주는 다음과 같습니다: Mr. Joshua Ruch

GeneDx Holdings Corp의 최대 수익원은 무엇인가요?

2026Q4 기준, GeneDx Holdings Corp의 Patients with third party insurance 부문이 가장 높은 매출을 기록했으며, 금액은 345.24M로 전체 매출의 80.75%를 차지했습니다.